 | • レポートコード：GIR-105X13473 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペプチドAPIのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペプチドAPIの種類別市場規模（液相ペプチド合成（LPPS）、固相ペプチド合成（SPPS））、用途別市場規模（がん、糖尿病、肥満、出産、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペプチドAPIの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：CordenPharma、PolyPeptide、Bachem、AmbioPharm、Pepscan、BCN Peptides、Senn Chemicals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：液相ペプチド合成（LPPS）、固相ペプチド合成（SPPS） ・用途別分析2016年-2026年：がん、糖尿病、肥満、出産、その他 ・ペプチドAPIの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペプチドAPIのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペプチドAPIのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペプチドAPIの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペプチドAPIの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Peptide APIs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Peptide APIs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Peptide APIs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Peptide APIs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Market segment by Application can be divided into
Cancer
Diabetes
Obesity
Fertility
Other
The key market players for global Peptide APIs market are listed below:
CordenPharma
PolyPeptide
Bachem
AmbioPharm
Pepscan
BCN Peptides
Senn Chemicals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Peptide APIs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptide APIs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Liquid Phase Peptide Synthesis (LPPS)
1.2.3 Solid Phase Peptide Synthesis (SPPS)
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptide APIs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Obesity
1.3.5 Fertility
1.3.6 Other
1.4 Global Peptide APIs Market Size & Forecast
1.4.1 Global Peptide APIs Sales in Value (2016-2026))
1.4.2 Global Peptide APIs Sales in Volume (2016-2026)
1.4.3 Global Peptide APIs Price by Type (2016-2026) & (USD/MT)
1.5 Global Peptide APIs Production Capacity Analysis
1.5.1 Global Peptide APIs Total Production Capacity (2016-2026)
1.5.2 Global Peptide APIs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peptide APIs Market Drivers
1.6.2 Peptide APIs Market Restraints
1.6.3 Peptide APIs Trends Analysis
2 Manufacturers Profiles
2.1 CordenPharma
2.1.1 CordenPharma Details
2.1.2 CordenPharma Major Business
2.1.3 CordenPharma Peptide APIs Product and Services
2.1.4 CordenPharma Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 PolyPeptide
2.2.1 PolyPeptide Details
2.2.2 PolyPeptide Major Business
2.2.3 PolyPeptide Peptide APIs Product and Services
2.2.4 PolyPeptide Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bachem
2.3.1 Bachem Details
2.3.2 Bachem Major Business
2.3.3 Bachem Peptide APIs Product and Services
2.3.4 Bachem Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 AmbioPharm
2.4.1 AmbioPharm Details
2.4.2 AmbioPharm Major Business
2.4.3 AmbioPharm Peptide APIs Product and Services
2.4.4 AmbioPharm Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pepscan
2.5.1 Pepscan Details
2.5.2 Pepscan Major Business
2.5.3 Pepscan Peptide APIs Product and Services
2.5.4 Pepscan Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 BCN Peptides
2.6.1 BCN Peptides Details
2.6.2 BCN Peptides Major Business
2.6.3 BCN Peptides Peptide APIs Product and Services
2.6.4 BCN Peptides Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Senn Chemicals
2.7.1 Senn Chemicals Details
2.7.2 Senn Chemicals Major Business
2.7.3 Senn Chemicals Peptide APIs Product and Services
2.7.4 Senn Chemicals Peptide APIs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Peptide APIs Sales by Manufacturer
3.1 Global Peptide APIs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Peptide APIs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Peptide APIs
3.4 Market Concentration Rate
3.4.1 Top 3 Peptide APIs Manufacturer Market Share
3.4.2 Top 6 Peptide APIs Manufacturer Market Share
3.5 Global Peptide APIs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Peptide APIs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peptide APIs Market Size by Region
4.1.1 Global Peptide APIs Sales in Volume by Region (2016-2026)
4.1.2 Global Peptide APIs Revenue by Region (2016-2026)
4.2 North America Peptide APIs Revenue (2016-2026)
4.3 Europe Peptide APIs Revenue (2016-2026)
4.4 Asia-Pacific Peptide APIs Revenue (2016-2026)
4.5 South America Peptide APIs Revenue (2016-2026)
4.6 Middle East and Africa Peptide APIs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Peptide APIs Sales in Volume by Type (2016-2026)
5.2 Global Peptide APIs Revenue by Type (2016-2026)
5.3 Global Peptide APIs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Peptide APIs Sales in Volume by Application (2016-2026)
6.2 Global Peptide APIs Revenue by Application (2016-2026)
6.3 Global Peptide APIs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Peptide APIs Sales by Type (2016-2026)
7.2 North America Peptide APIs Sales by Application (2016-2026)
7.3 North America Peptide APIs Market Size by Country
7.3.1 North America Peptide APIs Sales in Volume by Country (2016-2026)
7.3.2 North America Peptide APIs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Peptide APIs Sales by Type (2016-2026)
8.2 Europe Peptide APIs Sales by Application (2016-2026)
8.3 Europe Peptide APIs Market Size by Country
8.3.1 Europe Peptide APIs Sales in Volume by Country (2016-2026)
8.3.2 Europe Peptide APIs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Peptide APIs Sales by Type (2016-2026)
9.2 Asia-Pacific Peptide APIs Sales by Application (2016-2026)
9.3 Asia-Pacific Peptide APIs Market Size by Region
9.3.1 Asia-Pacific Peptide APIs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Peptide APIs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Peptide APIs Sales by Type (2016-2026)
10.2 South America Peptide APIs Sales by Application (2016-2026)
10.3 South America Peptide APIs Market Size by Country
10.3.1 South America Peptide APIs Sales in Volume by Country (2016-2026)
10.3.2 South America Peptide APIs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peptide APIs Sales by Type (2016-2026)
11.2 Middle East & Africa Peptide APIs Sales by Application (2016-2026)
11.3 Middle East & Africa Peptide APIs Market Size by Country
11.3.1 Middle East & Africa Peptide APIs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Peptide APIs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Peptide APIs Typical Distributors
12.3 Peptide APIs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Peptide APIs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Peptide APIs Revenue by Application, (USD Million), 2021-2026
Table 3. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 4. CordenPharma Major Business
Table 5. CordenPharma Peptide APIs Product and Services
Table 6. CordenPharma Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. PolyPeptide Basic Information, Manufacturing Base and Competitors
Table 8. PolyPeptide Major Business
Table 9. PolyPeptide Peptide APIs Product and Services
Table 10. PolyPeptide Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bachem Basic Information, Manufacturing Base and Competitors
Table 12. Bachem Major Business
Table 13. Bachem Peptide APIs Product and Services
Table 14. Bachem Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 16. AmbioPharm Major Business
Table 17. AmbioPharm Peptide APIs Product and Services
Table 18. AmbioPharm Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pepscan Basic Information, Manufacturing Base and Competitors
Table 20. Pepscan Major Business
Table 21. Pepscan Peptide APIs Product and Services
Table 22. Pepscan Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BCN Peptides Basic Information, Manufacturing Base and Competitors
Table 24. BCN Peptides Major Business
Table 25. BCN Peptides Peptide APIs Product and Services
Table 26. BCN Peptides Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Senn Chemicals Basic Information, Manufacturing Base and Competitors
Table 28. Senn Chemicals Major Business
Table 29. Senn Chemicals Peptide APIs Product and Services
Table 30. Senn Chemicals Peptide APIs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Peptide APIs Sales by Manufacturer (2019-2021e) & (K MT)
Table 32. Global Peptide APIs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Peptide APIs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Peptide APIs Production Capacity by Company, (K MT): 2020 VS 2021
Table 35. Head Office and Peptide APIs Production Site of Key Manufacturer
Table 36. Global Peptide APIs Sales by Region (2016-2021e) & (K MT)
Table 37. Global Peptide APIs Sales by Region (2021-2026) & (K MT)
Table 38. Global Peptide APIs Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Peptide APIs Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Peptide APIs Sales by Type (2016-2021e) & (K MT)
Table 41. Global Peptide APIs Sales by Type (2021-2026) & (K MT)
Table 42. Global Peptide APIs Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Peptide APIs Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Peptide APIs Price by Type (2016-2021e) & (USD/MT)
Table 45. Global Peptide APIs Price by Type (2021-2026) & (USD/MT)
Table 46. Global Peptide APIs Sales by Application (2016-2021e) & (K MT)
Table 47. Global Peptide APIs Sales by Application (2021-2026) & (K MT)
Table 48. Global Peptide APIs Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Peptide APIs Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Peptide APIs Price by Application (2016-2021e) & (USD/MT)
Table 51. Global Peptide APIs Price by Application (2021-2026) & (USD/MT)
Table 52. North America Peptide APIs Sales by Country (2016-2021e) & (K MT)
Table 53. North America Peptide APIs Sales by Country (2021-2026) & (K MT)
Table 54. North America Peptide APIs Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Peptide APIs Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Peptide APIs Sales by Type (2016-2021e) & (K MT)
Table 57. North America Peptide APIs Sales by Type (2021-2026) & (K MT)
Table 58. North America Peptide APIs Sales by Application (2016-2021e) & (K MT)
Table 59. North America Peptide APIs Sales by Application (2021-2026) & (K MT)
Table 60. Europe Peptide APIs Sales by Country (2016-2021e) & (K MT)
Table 61. Europe Peptide APIs Sales by Country (2021-2026) & (K MT)
Table 62. Europe Peptide APIs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Peptide APIs Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Peptide APIs Sales by Type (2016-2021e) & (K MT)
Table 65. Europe Peptide APIs Sales by Type (2021-2026) & (K MT)
Table 66. Europe Peptide APIs Sales by Application (2016-2021e) & (K MT)
Table 67. Europe Peptide APIs Sales by Application (2021-2026) & (K MT)
Table 68. Asia-Pacific Peptide APIs Sales by Region (2016-2021e) & (K MT)
Table 69. Asia-Pacific Peptide APIs Sales by Region (2021-2026) & (K MT)
Table 70. Asia-Pacific Peptide APIs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Peptide APIs Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Peptide APIs Sales by Type (2016-2021e) & (K MT)
Table 73. Asia-Pacific Peptide APIs Sales by Type (2021-2026) & (K MT)
Table 74. Asia-Pacific Peptide APIs Sales by Application (2016-2021e) & (K MT)
Table 75. Asia-Pacific Peptide APIs Sales by Application (2021-2026) & (K MT)
Table 76. South America Peptide APIs Sales by Country (2016-2021e) & (K MT)
Table 77. South America Peptide APIs Sales by Country (2021-2026) & (K MT)
Table 78. South America Peptide APIs Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Peptide APIs Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Peptide APIs Sales by Type (2016-2021e) & (K MT)
Table 81. South America Peptide APIs Sales by Type (2021-2026) & (K MT)
Table 82. South America Peptide APIs Sales by Application (2016-2021e) & (K MT)
Table 83. South America Peptide APIs Sales by Application (2021-2026) & (K MT)
Table 84. Middle East & Africa Peptide APIs Sales by Country (2016-2021e) & (K MT)
Table 85. Middle East & Africa Peptide APIs Sales by Country (2021-2026) & (K MT)
Table 86. Middle East & Africa Peptide APIs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Peptide APIs Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Peptide APIs Sales by Type (2016-2021e) & (K MT)
Table 89. Middle East & Africa Peptide APIs Sales by Type (2021-2026) & (K MT)
Table 90. Middle East & Africa Peptide APIs Sales by Application (2016-2021e) & (K MT)
Table 91. Middle East & Africa Peptide APIs Sales by Application (2021-2026) & (K MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Peptide APIs Typical Distributors
Table 95. Peptide APIs Typical Customers
List of Figures
Figure 1. Peptide APIs Picture
Figure 2. Global Peptide APIs Sales Market Share by Type in 2020
Figure 3. Liquid Phase Peptide Synthesis (LPPS)
Figure 4. Solid Phase Peptide Synthesis (SPPS)
Figure 5. Global Peptide APIs Sales Market Share by Application in 2020
Figure 6. Cancer
Figure 7. Diabetes
Figure 8. Obesity
Figure 9. Fertility
Figure 10. Other
Figure 11. Global Peptide APIs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Peptide APIs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Peptide APIs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Peptide APIs Sales (2016-2026) & (K MT)
Figure 33. Global Peptide APIs Production Capacity (2016-2026) & (K MT)
Figure 34. Global Peptide APIs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Peptide APIs Market Drivers
Figure 36. Peptide APIs Market Restraints
Figure 37. Peptide APIs Market Trends
Figure 38. Global Peptide APIs Sales Market Share by Manufacturer in 2020
Figure 39. Global Peptide APIs Revenue Market Share by Manufacturer in 2020
Figure 40. Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Peptide APIs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Peptide APIs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Peptide APIs Sales Market Share by Region (2016-2026)
Figure 44. Global Peptide APIs Revenue Market Share by Region (2016-2026)
Figure 45. North America Peptide APIs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Peptide APIs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Peptide APIs Revenue (2016-2026) & (USD Million)
Figure 48. South America Peptide APIs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Peptide APIs Revenue (2016-2026) & (USD Million)
Figure 50. Global Peptide APIs Sales Market Share by Type (2016-2026)
Figure 51. Global Peptide APIs Revenue Market Share by Type (2016-2026)
Figure 52. Global Peptide APIs Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Peptide APIs Sales Market Share by Application (2016-2026)
Figure 54. Global Peptide APIs Revenue Market Share by Application (2016-2026)
Figure 55. Global Peptide APIs Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Peptide APIs Sales Market Share by Country (2016-2026)
Figure 57. North America Peptide APIs Revenue Market Share by Country (2016-2026)
Figure 58. North America Peptide APIs Sales Market Share by Type (2016-2026)
Figure 59. North America Peptide APIs Sales Market Share by Application (2016-2026)
Figure 60. Europe Peptide APIs Sales Market Share by Country (2016-2026)
Figure 61. Europe Peptide APIs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Peptide APIs Sales Market Share by Type (2016-2026)
Figure 63. Europe Peptide APIs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Peptide APIs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Peptide APIs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Peptide APIs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Peptide APIs Sales Market Share by Application (2016-2026)
Figure 68. South America Peptide APIs Sales Market Share by Country (2016-2026)
Figure 69. South America Peptide APIs Revenue Market Share by Country (2016-2026)
Figure 70. South America Peptide APIs Sales Market Share by Type (2016-2026)
Figure 71. South America Peptide APIs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Peptide APIs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Peptide APIs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Peptide APIs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Peptide APIs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
ペプチド癌ワクチンの世界市場2018-2025 This study researches the market size of Peptide Cancer Vaccine, presents the global Peptide Cancer Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Peptide Cancer …- 世界の銅ペプチド市場 2021：企業別、地域別、種類・用途別 The Copper Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のペプチドビルディングブロック市場 2021：企業別、地域別、種類・用途別 The Peptide Building Block market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 卵白ペプチドの世界市場2018-2025 Leading producers of egg white peptides are focused toward securing regulatory health claims. Key market participants are employing new approaches for maintaining vascular health by integrating medical care, specialized nutrition, and early diagnostics, in a bid to offer more effective products that…
- 世界の米タンパク質ペプチド粉末市場 2021：企業別、地域別、種類・用途別 The Rice Protein Peptide Powder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…